| Patients
with hypertension who undergo long-term treatment with melatonin have lower nighttime
blood pressure, according to a study reported in the January 20 rapid access issue
of Hypertension. This
finding suggests that melatonin, a naturally occurring hormone in the body, might
be a beneficial addition to traditional high blood pressure treatments. Lead
author Frank Scheer, a neuroscientist at Brigham and Women's Hospital, said melatonin's
effect on blood pressure might be due to its ability to help regulate the body's
biological clock. "It
has been reported that people with high blood pressure often have suppressed nighttime
melatonin levels," Scheer said. "We have recently found that people
with high blood pressure have actual anatomical disturbances of their biological
clocks. This finding might open the door for a new approach for treating hypertension."
The researchers
evaluated the effect of melatonin after one dose and after a three-week treatment
regimen in their study of 16 men. Patients taking repeated melatonin had lower
nighttime systolic blood pressure by 6 mm Hg and diastolic blood pressure by 4
mm Hg. The single dose of melatonin had no effect on blood pressure. Patients
taking melatonin also reported improved sleep, but Scheer said that effect was
unrelated to blood pressure reduction in this study. While
this small study suggests the biological clock might be a mechanism involved in
the blood pressure reduction, Scheer and colleagues also believe that improved
sleep over a long time might help reduce blood pressure as well. Dr.
Dan Jones, a high blood pressure expert and an American Heart Association spokesperson,
cautioned that larger studies are needed before it can recommend melatonin to
fight high blood pressure. "Patients
with high blood pressure should consult their own health care provider for specific
advice, but no one should begin melatonin therapy for blood pressure management
for the time being," said Jones, who is dean of the University of Mississippi
Medical Center School of Medicine. Scheer
agreed, noting that the study is just a start. "Large-scale studies need
to be done, as well as studies of potential interactions between melatonin and
traditional antihypertensive treatments," he added. Other
sources: American Heart Association
|